#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    CDKL5 deficiency disorder Leukocyte adhesion deficiency type I Extra-osseous Ewing's sarcoma metastatic Glomerulonephritis rapidly progressive Neurotrophic keratopathy Anal squamous cell carcinoma Small cell lung cancer extensive stage Ovarian epithelial cancer Small intestine neuroendocrine tumour Multiple system atrophy Leiomyosarcoma Optic glioma Gastrooesophageal cancer Epileptic encephalopathy Anti-HLA antibody test positive More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Synovial sarcoma metastatic – Treatment Hereditary optic atrophy – Basic Information Cytokine release syndrome – Life with Disease Synovial sarcoma recurrent – Life with Disease Prader-Willi syndrome – Treatment Encephalitis autoimmune Haemophilia B without inhibitors – Life with Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Congenital hypotransferrinaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ly3541860 Anitocabtagene Autoleucel Teprotumumab Adapalene Vinblastine Sulfate Tpst-1120 Vincristine Anhydrous Caffeine VINBLASTINE Epirubicin Hydrochloride Anidulafungin Voxelotor Vincristine Sulfate HYDROXYCHLOROQUINE Glenzocimab INDAPAMIDE HEMIHYDRATE Meropenem Anhydrous Gadoteric Acid Dried Ferrous Sulfate Methylphenidate Hydrochloride More therapies…

    Learn about Your Condition

    Venous thrombosis Fontan procedure Laryngeal leukoplakia Testis cancer Aplasia pure red cell Schizophreniform disorder Encephalitis autoimmune Iron overload Small cell carcinoma Alport's syndrome Osteosarcoma Neonatal asphyxia Skin wrinkling Dermatomyositis Lymphangioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bulgaria

  • Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

    Recruiting

    3 1
    Investigated Drugs:
    • Telitacicept
    Belgium Bulgaria Czechia Denmark France Italy +2
  • Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    Belgium Bulgaria Denmark Ireland Italy The Netherlands +4
  • Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • ABBV-8736
    • Humanised Igg1 Kappa Monoclonal Antibody Against Alfa4Beta7 Integrin
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
  • A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

    Recruiting

    3 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    • Depemokimab
    Belgium Bulgaria Denmark France Germany Greece +6
  • Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Austria Bulgaria Czechia France Germany Greece +8
  • Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Bulgaria Czechia Denmark Finland France Germany +8
Previous Page
1 … 41 42 43 44 45 … 138
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Dexamethasone Semaglutide Upadacitinib Sodium Chloride Mycophenolate Mofetil Efgartigimod Alfa Pemetrexed Prednisone Dapagliflozin Rituximab Fulvestrant Xanomeline Tartrate Paclitaxel Prednisolone Ruxolitinib Risankizumab Paracetamol Durvalumab Remibrutinib Letrozole Salbutamol Sulfate Trospium Chloride Salbutamol Glycopyrronium Bromide Formoterol Fumarate Dihydrate Zasocitinib Guselkumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Abdominal infection Acquired ATTR amyloidosis Acquired C1 inhibitor deficiency Acromegaly Acute coronary syndrome Acute haemorrhagic ulcerative colitis Acute hepatic failure Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Acute respiratory distress syndrome Acute respiratory failure Adenomyosis Adrenogenital syndrome Alcoholic liver disease Alopecia areata Anaemia Anaemia of chronic disease Anal incontinence Angina pectoris Anhedonia Ankylosing spondylitis Arteriosclerosis Arteriovenous graft thrombosis Asthma Asthmatic crisis Atrial fibrillation Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bacterial infection Bipolar disorder Bipolar I disorder Bladder cancer Breast cancer Breast cancer metastatic Bronchiectasis Cachexia Cardiac ablation Cardiac amyloidosis Cardiac failure Cardiac failure chronic Cardiovascular disorder Central nervous system melanoma Cerebrovascular accident prophylaxis Cervix carcinoma recurrent Cholangiocarcinoma Cholestatic pruritus Chronic cutaneous lupus erythematosus Chronic graft versus host disease Chronic hepatitis Chronic hepatitis B Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Chronic sinusitis Chronic spontaneous urticaria Clear cell renal cell carcinoma Clostridium difficile infection Coagulation factor X level Cognitive disorder Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Conjunctivitis allergic Connective tissue disorder Constipation COVID-19 Crohn's disease Cushing's syndrome Cutaneous lupus erythematosus Deep vein thrombosis Dementia Alzheimer's type Dementia of the Alzheimer's type with delusions Dementia with Lewy bodies Dermatitis Dermatitis atopic Dermatomyositis Diabetic foot infection Diabetic neuropathy Diabetic retinal oedema Diffuse large B-cell lymphoma Dilated cardiomyopathy Dry age-related macular degeneration Dry eye Duchenne muscular dystrophy Dyslipidaemia Eczema nummular EGFR gene mutation Embolism Embolism venous Endocrine ophthalmopathy Endometrial adenocarcinoma Endometrial cancer Endometriosis Epilepsy Epstein-Barr virus associated lymphoma Erosive oesophagitis Ex-tobacco user Eyelid ptosis Factor IX deficiency Factor VIII deficiency Fallopian tube cancer Familial hypertriglyceridaemia Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastrointestinal cancer metastatic Gastrointestinal melanoma Gastrooesophageal reflux disease Generalised anxiety disorder Generalised tonic-clonic seizure Genital herpes simplex Gout Haematological infection Haemophilia A with anti factor VIII Haemophilia A without inhibitors Haemophilia B without inhibitors Hepatic cirrhosis Hepatic encephalopathy Hepatic function abnormal Hepatitis B Hepatitis D Hepatitis viral Hepatocellular carcinoma HER2 positive breast cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemorrhagic telangiectasia Hereditary neuropathic amyloidosis Hidradenitis High-grade B-cell lymphoma Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Huntington's disease Hypercholesterolaemia Hyperchylomicronaemia Hyperinsulinaemic hypoglycaemia Hyperinsulinism Hyperparathyroidism secondary Hypertension Hypertriglyceridaemia Hypertrophic cardiomyopathy Idiopathic inflammatory myopathy Idiopathic pulmonary fibrosis IgA nephropathy Immune thrombocytopenia Inborn error of metabolism Indolent systemic mastocytosis Infection prophylaxis Influenza Influenza immunisation Insomnia Iridocyclitis Iron deficiency Ischaemic stroke Juvenile idiopathic arthritis Left ventricular dysfunction Lung adenocarcinoma Lupus nephritis Macular oedema Magnetic resonance imaging Major depression Malignant melanoma Malignant melanoma of eyelid Malignant melanoma stage III Malignant melanoma stage IV Malignant urinary tract neoplasm Mania Marginal zone lymphoma Melanoma recurrent Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metapneumovirus infection Metastatic malignant melanoma Migraine Motion sickness Multiple sclerosis Multiple sclerosis relapse Muscle spasticity Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myeloproliferative neoplasm Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephrogenic anaemia Nervous system disorder Netherton's syndrome Neuralgia Neurodermatitis Neuroendocrine carcinoma Neuropathy peripheral Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Noonan syndrome Obesity Open angle glaucoma Osteoarthritis Osteoporosis Osteoporosis postmenopausal Ovarian cancer Ovarian epithelial cancer Overweight Pain Pancreatic carcinoma metastatic Pancreatic failure Papulopustular rosacea Paranasal sinus inflammation Parkinson's disease Partial seizures Pemphigoid Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Pneumonia Polycythaemia vera Polymyositis Porphyria non-acute Post herpetic neuralgia Postoperative analgesia Pre-eclampsia Primary biliary cholangitis Primary myelofibrosis Primary progressive multiple sclerosis Progressive multiple sclerosis Progressive relapsing multiple sclerosis Progressive supranuclear palsy Prophylaxis against motion sickness Prostate cancer Prostate cancer metastatic Proteinuria Psoriasis Psoriatic arthropathy Psychotic disorder Pulmonary arterial hypertension Pulmonary hypertension Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cell carcinoma Respiratory syncytial virus infection Retinal vein occlusion Retinopathy of prematurity Rheumatoid arthritis Rhinitis allergic Schizophrenia Secondary progressive multiple sclerosis Seizure Sepsis Short stature Sinusitis noninfective Sjogren's syndrome Skin bacterial infection Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer recurrent Small for dates baby Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Squamous cell carcinoma of skin Still's disease Subacute cutaneous lupus erythematosus Systemic candida Systemic lupus erythematosus Systemic scleroderma Tardive dyskinesia Thalassaemia Thrombocytopenia Thrombolysis Thrombosis prophylaxis Tourette's disorder Transient ischaemic attack Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Triple negative breast cancer Turner's syndrome Type 2 diabetes mellitus Type IIa hyperlipidaemia Urea cycle disorder Urinary tract infection Varicella Vernal keratoconjunctivitis Vitiligo Warm autoimmune haemolytic anaemia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!